Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 2 | -$0.09 | -$0.03 | -$0.05 |
Q2 2025 | 1 | -$0.04 | -$0.04 | -$0.04 |
Q3 2025 | 1 | -$0.03 | -$0.03 | -$0.03 |
Q4 2025 | 1 | -$0.03 | -$0.02 | -$0.03 |
Q1 2026 | 1 | $0.01 | $0.01 | $0.01 |
Q2 2026 | 1 | $0.02 | $0.02 | $0.02 |
Q3 2026 | 1 | $0.02 | $0.02 | $0.02 |
Q4 2026 | 1 | $0.04 | $0.04 | $0.04 |
Q1 2027 | 0 | $0.00 | $0.00 | $0.00 |
Q2 2027 | 0 | $0.00 | $0.00 | $0.00 |
Q3 2027 | 0 | $0.00 | $0.00 | $0.00 |
Q4 2027 | 0 | $0.00 | $0.00 | $0.00 |
BioLife Solutions, Inc. last posted its earnings results on Tuesday, November 12th, 2024. The company reported $-0.02 earnings per share for the quarter, topping analysts' consensus estimates of $-0.09 by $0.07. The company had revenue of 30.57 M for the quarter and had revenue of 143.27 M for the year. BioLife Solutions, Inc. has generated $-2 earnings per share over the last year ($-1.52 diluted earnings per share) and currently has a price-to-earnings ratio of -26.22. BioLife Solutions, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/12/2024 | Q3 2024 | -$0.09 | -$0.04 | 0.05 | $25.54 M | $30.57 M |
08/09/2024 | Q2 2024 | -$0.45 | $23.95 M | $28.33 M | ||
05/10/2024 | Q1 2024 | -$0.22 | $31.73 M | |||
02/29/2024 | Q4 2023 | -$0.36 | -$0.30 | 0.06 | $32.73 M | |
11/09/2023 | Q3 2023 | -$0.38 | -$0.67 | -0.29 | $33.01 M | $33.33 M |
08/09/2023 | Q2 2023 | -$0.23 | $43.64 M | $39.51 M | ||
05/11/2023 | Q1 2023 | -$0.32 | $37.70 M | |||
03/31/2023 | Q4 2022 | -$1.15 | $44.26 M | |||
11/09/2022 | Q3 2022 | -$0.18 | -$0.23 | -0.05 | $42.06 M | $40.75 M |
08/09/2022 | Q2 2022 | -$0.20 | -$1.71 | -1.51 | $39.17 M | $40.53 M |
05/10/2022 | Q1 2022 | -$0.17 | $36.22 M | |||
03/31/2022 | Q4 2021 | -$0.37 | $37.30 M | |||
11/15/2021 | Q3 2021 | $0.00 | $31.59 M | $33.80 M | ||
08/16/2021 | Q2 2021 | $0.20 | $27.58 M | $31.20 M | ||
05/17/2021 | Q1 2021 | -$0.03 | $16.85 M | |||
03/31/2021 | Q4 2020 | -$0.06 | $14.73 M | |||
11/09/2020 | Q3 2020 | -$0.04 | $10.78 M | $11.28 M | ||
08/10/2020 | Q2 2020 | -$0.70 | $9.57 M | $9.92 M | ||
05/29/2020 | Q1 2020 | $0.87 | $12.16 M | |||
05/15/2020 | Q4 2019 | $0.02 | $8.30 M |
BioLife Solutions, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
In the previous quarter, BioLife Solutions, Inc. (:BLFS) reported $-0.02 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.09 by $0.07.
The conference call for BioLife Solutions, Inc.'s latest earnings report can be listened to online.
The conference call transcript for BioLife Solutions, Inc.'s latest earnings report can be read online.
BioLife Solutions, Inc. (:BLFS) has a recorded annual revenue of $143.27 M.
BioLife Solutions, Inc. (:BLFS) has a recorded net income of $143.27 M. BioLife Solutions, Inc. has generated $-1.52 earnings per share over the last four quarters.
BioLife Solutions, Inc. (:BLFS) has a price-to-earnings ratio of -26.22 and price/earnings-to-growth ratio is -0.68.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED